Medical Developments International Ltd. announced that Penthrox has been launched in Italy. There has been a number of clinical studies completed in preparation for the launch of Penthrox in Italy. In particular, a study of 272 trauma patients in 15 Italian emergency units (MEDITA), showed that Penthrox was SUPERIOR to Standard of Care, including Opioids, for adult trauma pain patients in Italy. The launch of Penthrox in Italy will trigger another milestone payment from the partner Mundipharma of USD 2 million which is expected during 2020. Penthrox is now well placed to develop into a leading trauma pain medication in Italy and throughout Europe.